{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:24:27Z","timestamp":1784733867965,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20224Y0372"],"award-info":[{"award-number":["20224Y0372"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173429"],"award-info":[{"award-number":["82173429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102418"],"award-info":[{"award-number":["82102418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04230-x","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T18:40:53Z","timestamp":1754332853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro and in vivo antifungal activity of Minocycline albumin nanoparticles in combination with fluconazole against azole-resistant Candida spp"],"prefix":"10.1186","volume":"25","author":[{"given":"Lulu","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizhen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"4230_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/antibiotics9120877","volume":"9","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Gabald\u00f3n T, Garcia-Rubio R, Jenks JD, Hoenigl M, Salzer HJF, Ilkit M, Lass-Fl\u00f6rl C, Perlin DS. Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium. Antibiot (Basel). 2020;9:877.","journal-title":"Antibiot (Basel)"},{"key":"4230_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12879-021-05780-x","volume":"21","author":"D Li","year":"2021","unstructured":"Li D, Li T, Bai C, Zhang Q, Li Z, Li X. A predictive nomogram for mortality of cancer patients with invasive candidiasis: a 10-year study in a cancer center of North China. BMC Infect Dis. 2021;21:76.","journal-title":"BMC Infect Dis"},{"key":"4230_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11046-023-00757-7","volume":"188","author":"M Chen","year":"2023","unstructured":"Chen M, Hu D, Li T, Zheng D, Liao W, Xia X, Cao C. The epidemiology and clinical characteristics of fungemia in a tertiary hospital in Southern china: a 6-year retrospective study. Mycopathologia. 2023;188:353\u201360.","journal-title":"Mycopathologia"},{"key":"4230_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2217\/fmb-2019-0342","volume":"15","author":"GS Arita","year":"2020","unstructured":"Arita GS, Faria DR, Sakita KM, Rodrigues-Vendramini FA, Capoci IR, Kioshima ES, Bonfim-Mendon\u00e7a PS, Svidzinski TI. Impact of serial systemic infection on Candida albicans virulence factors. Future Microbiol. 2020;15:1249\u201363.","journal-title":"Future Microbiol"},{"key":"4230_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jinf.2015.12.008","volume":"72","author":"EM Maiolo","year":"2016","unstructured":"Maiolo EM, Oliva A, Furustrand Tafin U, Perrotet N, Borens O, Trampuz A. Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection. J Infect. 2016;72:386\u201392.","journal-title":"J Infect"},{"key":"4230_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.reprotox.2020.12.018","volume":"100","author":"MC Budani","year":"2021","unstructured":"Budani MC, Fensore S, Di Marzio M, Tiboni GM. Maternal use of fluconazole and congenital malformations in the progeny: a meta-analysis of the literature. Reprod Toxicol. 2021;100:42\u201351.","journal-title":"Reprod Toxicol"},{"key":"4230_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jgar.2023.10.019","volume":"35","author":"Y Feng","year":"2023","unstructured":"Feng Y, Lu H, Whiteway M, Jiang Y. Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections. J Glob Antimicrob Resist. 2023;35:314\u201321.","journal-title":"J Glob Antimicrob Resist"},{"key":"4230_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/1040841X.2021.1884641","volume":"47","author":"H Lu","year":"2021","unstructured":"Lu H, Shrivastava M, Whiteway M, Jiang Y. Candida albicans targets that potentially synergize with fluconazole. Crit Rev Microbiol. 2021;47:323\u201337.","journal-title":"Crit Rev Microbiol"},{"key":"4230_CR9","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1021\/acs.jmedchem.3c00165","volume":"66","author":"Z Li","year":"2023","unstructured":"Li Z, Huang Y, Tu J, Yang W, Liu N, Wang W, Sheng C. Discovery of BRD4-HDAC dual inhibitors with improved fungal selectivity and potent synergistic antifungal activity against fluconazole-resistant Candida albicans. J Med Chem. 2023;66:5950\u201364.","journal-title":"J Med Chem"},{"key":"4230_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;48:503\u201335.","journal-title":"Clin Infect Dis"},{"key":"4230_CR11","doi-asserted-by":"publisher","first-page":"692693","DOI":"10.3389\/fmicb.2021.692693","volume":"12","author":"LY Su","year":"2021","unstructured":"Su LY, Ni GH, Liao YC, Su LQ, Li J, Li JS, Rao GX, Wang RR. Antifungal activity and potential mechanism of 6,7,4\u2019-O-triacetylscutellarein combined with fluconazole against drug-resistant C. albicans. Front Microbiol. 2021;12:692693.","journal-title":"Front Microbiol"},{"key":"4230_CR12","doi-asserted-by":"publisher","first-page":"e0072522","DOI":"10.1128\/aac.00725-22","volume":"66","author":"L An","year":"2022","unstructured":"An L, Tan J, Wang Y, Liu S, Li Y, Yang L. Synergistic effect of the combination of deferoxamine and fluconazole in vitro and in vivo against fluconazole-resistant Candida spp. Antimicrob Agents Chemother. 2022;66:e0072522.","journal-title":"Antimicrob Agents Chemother"},{"key":"4230_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/jac\/dkr512","volume":"67","author":"MS Khan","year":"2012","unstructured":"Khan MS, Ahmad I. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J Antimicrob Chemother. 2012;67:618\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"4230_CR14","doi-asserted-by":"publisher","first-page":"649026","DOI":"10.3389\/fmicb.2021.649026","volume":"12","author":"J Tan","year":"2021","unstructured":"Tan J, Jiang S, Tan L, Shi H, Yang L, Sun Y, Wang X. Antifungal activity of Minocycline and Azoles against fluconazole-resistant Candida species. Front Microbiol. 2021;12:649026.","journal-title":"Front Microbiol"},{"key":"4230_CR15","doi-asserted-by":"publisher","first-page":"e00290","DOI":"10.1128\/AAC.00290-20","volume":"64","author":"L Gao","year":"2020","unstructured":"Gao L, Sun Y, Yuan M, Li M, Zeng T. In vitro and in vivo Study on the synergistic effect of minocycline and azoles against pathogenic fungi. Antimicrob Agents Chemother. 2020;64:e00290-20.","journal-title":"Antimicrob Agents Chemother."},{"key":"4230_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1567-1364.2010.00664.x","volume":"10","author":"W Shi","year":"2010","unstructured":"Shi W, Chen Z, Chen X, Cao L, Liu P, Sun S. The combination of Minocycline and fluconazole causes synergistic growth Inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res. 2010;10:885\u201393.","journal-title":"FEMS Yeast Res"},{"key":"4230_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother. 2006;58:256\u201365.","journal-title":"J Antimicrob Chemother"},{"key":"4230_CR18","first-page":"221","volume":"7","author":"TS Kashi","year":"2012","unstructured":"Kashi TS, Eskandarion S, Esfandyari-Manesh M, Marashi SM, Samadi N, Fatemi SM, Atyabi F, Eshraghi S, Dinarvand R. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid\/oil\/water ion pairing method. Int J Nanomed. 2012;7:221\u201334.","journal-title":"Int J Nanomed"},{"key":"4230_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.nano.2012.03.004","volume":"9","author":"JM Kaiser","year":"2013","unstructured":"Kaiser JM, Imai H, Haakenson JK, Brucklacher RM, Fox TE, Shanmugavelandy SS, Unrath KA, Pedersen MM, Dai P, Freeman WM, Bronson SK, Gardner TW, Kester M. Nanoliposomal Minocycline for ocular drug delivery. Nanomedicine. 2013;9:130\u201340.","journal-title":"Nanomedicine"},{"key":"4230_CR20","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","volume":"10","author":"T Lin","year":"2016","unstructured":"Lin T, Zhao P, Jiang Y, Tang Y, Jin H, Pan Z, He H, Yang VC, Huang Y. Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy. ACS Nano. 2016;10:9999\u201310012.","journal-title":"ACS Nano"},{"key":"4230_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejps.2017.05.066","volume":"106","author":"MJ de Jes\u00fas Valle","year":"2017","unstructured":"de Jes\u00fas Valle MJ, Maderuelo Mart\u00edn C, Zarzuelo Casta\u00f1eda A, S\u00e1nchez Navarro A. Albumin micro\/nanoparticles entrapping liposomes for Itraconazole green formulation. Eur J Pharm Sci. 2017;106:159\u201365.","journal-title":"Eur J Pharm Sci"},{"key":"4230_CR22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/acsbiomaterials.0c01084","volume":"7","author":"L Yang","year":"2021","unstructured":"Yang L, Liu Y, Wang N, Wang H, Wang K, Luo XL, Dai RX, Tao RJ, Wang HJ, Yang JW, Tao GQ, Qu JM, Ge BX, Li YY, Xu JF. Albumin-based LL37 peptide nanoparticles as a sustained release system against Pseudomonas aeruginosa lung infection. ACS Biomater Sci Eng. 2021;7:1817\u201326.","journal-title":"ACS Biomater Sci Eng"},{"key":"4230_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jconrel.2020.12.035","volume":"330","author":"L Hao","year":"2021","unstructured":"Hao L, Zhou Q, Piao Y, Zhou Z, Tang J, Shen Y. Albumin-binding prodrugs via reversible Iminoboronate forming nanoparticles for cancer drug delivery. J Control Release. 2021;330:362\u201371.","journal-title":"J Control Release"},{"key":"4230_CR24","doi-asserted-by":"publisher","first-page":"120849","DOI":"10.1016\/j.biomaterials.2021.120849","volume":"274","author":"Y Han","year":"2021","unstructured":"Han Y, Liu Y, Ma X, Shen A, Liu Y, Weeranoppanant N, Dong H, Li Y, Ren T, Kuai L, Li B, An M, Li Y. Antibiotics armed neutrophils as a potential therapy for brain fungal infection caused by chemotherapy-induced neutropenia. Biomaterials. 2021;274:120849.","journal-title":"Biomaterials"},{"key":"4230_CR25","doi-asserted-by":"publisher","first-page":"1101553","DOI":"10.3389\/fphar.2022.1101553","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Ji Z, Feng Y, Yan T, Cao Y, Lu H, Jiang Y. Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1. Front Pharmacol. 2022;13:1101553.","journal-title":"Front Pharmacol"},{"key":"4230_CR26","first-page":"e02529","volume":"10","author":"SH Kim","year":"2019","unstructured":"Kim SH, Iyer KR, Pardeshi L, Mu\u00f1oz JF, Robbins N, Cuomo CA, Wong KH, Cowen LE. Genetic analysis of Candida auris implicates Hsp90 in morphogenesis and Azole tolerance and Cdr1 in Azole resistance. mBio. 2019;10:e02529\u201318.","journal-title":"mBio"},{"key":"4230_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1128\/AAC.00861-07","volume":"52","author":"R Pasrija","year":"2008","unstructured":"Pasrija R, Panwar SL, Prasad R. Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob Agents Chemother. 2008;52:694\u2013704.","journal-title":"Antimicrob Agents Chemother"},{"key":"4230_CR28","doi-asserted-by":"publisher","first-page":"e0174821","DOI":"10.1128\/AAC.01748-21","volume":"66","author":"M Niimi","year":"2022","unstructured":"Niimi M, Niimi K, Tanabe K, Cannon RD, Lamping E. Inhibitor-resistant mutants give important insights into Candida albicans ABC transporter Cdr1 substrate specificity and help elucidate efflux pump Inhibition. Antimicrob Agents Chemother. 2022;66:e0174821.","journal-title":"Antimicrob Agents Chemother"},{"key":"4230_CR29","doi-asserted-by":"publisher","first-page":"fov036","DOI":"10.1093\/femsyr\/fov036","volume":"15","author":"AH Shah","year":"2015","unstructured":"Shah AH, Banerjee A, Rawal MK, Saxena AK, Mondal AK, Prasad R. ABC transporter Cdr1p harbors charged residues in the intracellular loop and nucleotide-binding domain critical for protein trafficking and drug resistance. FEMS Yeast Res. 2015;15:fov036.","journal-title":"FEMS Yeast Res"},{"key":"4230_CR30","doi-asserted-by":"publisher","first-page":"103953","DOI":"10.1016\/j.isci.2022.103953","volume":"25","author":"KR Iyer","year":"2022","unstructured":"Iyer KR, Robbins N, Cowen LE. The role of Candida albicans stress response pathways in antifungal tolerance and resistance. iScience. 2022;25:103953.","journal-title":"iScience"},{"key":"4230_CR31","doi-asserted-by":"publisher","first-page":"47750","DOI":"10.1021\/acsami.9b17550","volume":"11","author":"L He","year":"2019","unstructured":"He L, Wang H, Han Y, Wang K, Dong H, Li Y, Shi D, Li Y. Remodeling of cellular surfaces via fast disulfide-thiol exchange to regulate cell behaviors. ACS Appl Mater Interfaces. 2019;11:47750\u201361.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4230_CR32","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. 4th ed. CLSI standard M27. Wayne: CLSI; 2017."},{"key":"4230_CR33","doi-asserted-by":"publisher","first-page":"e00154","DOI":"10.1128\/mSphere.00154-18","volume":"3","author":"VK Vyas","year":"2018","unstructured":"Vyas VK, Bushkin GG, Bernstein DA, Getz MA, Sewastianik M, Barrasa MI, Bartel DP, Fink GR. New CRISPR mutagenesis strategies reveal variation in repair mechanisms among fungi. mSphere. 2018;3:e00154\u201318.","journal-title":"mSphere"},{"issue":"11","key":"4230_CR34","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1039\/D4NH00161C","volume":"9","author":"SP Chali","year":"2024","unstructured":"Chali SP, Westmeier J, Krebs F, Jiang S, Neesen FP, Uncuer D, Schelhaas M, Grabbe S, Becker C, Landfester K, Steinbrink K. Albumin nanocapsules and nanocrystals for efficient intracellular drug release. Nanoscale Horiz. 2024;9(11):1978\u201389.","journal-title":"Nanoscale Horiz"},{"key":"4230_CR35","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.2147\/IJN.S467876","volume":"19","author":"N Qu","year":"2024","unstructured":"Qu N, Song K, Ji Y, Liu M, Chen L, Lee RJ, Teng L. Albumin Nanoparticle-Based drug delivery systems. Int J Nanomed. 2024;19:6945\u201380.","journal-title":"Int J Nanomed"},{"key":"4230_CR36","doi-asserted-by":"publisher","unstructured":"da Silva CR, Silveira MJCB, Soares GC, de Andrade CR, Cabral VPF, S\u00e1 LGDAV, Rodrigues DS, Moreira LEA, Barbosa AD, da Silva LJ, da Silva AR, Gomes AOCV, Cavalcanti BC, de Moraes MO. Nobre j\u00fanior HV, de Andrade Neto JB. Analysis of possible pathways on the mechanism of action of Minocycline and Doxycycline against strains of Candida spp. Resistant to fluconazole. J Med Microbiol. 2023;72(10). https:\/\/doi.org\/10.1099\/jmm.0.001759.","DOI":"10.1099\/jmm.0.001759"},{"issue":"3","key":"4230_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/brainsci13030402","volume":"13","author":"V Perumal","year":"2023","unstructured":"Perumal V, Ravula AR, Agas A, Gosain A, Aravind A, Sivakumar PM, I SS, Sambath K, Vijayaraghavalu S, Chandra N. Enhanced targeted delivery of Minocycline via transferrin conjugated albumin nanoparticle improves neuroprotection in a blast traumatic brain injury model. Brain Sci. 2023;13(3):402.","journal-title":"Brain Sci"},{"key":"4230_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/jof6030142","volume":"6","author":"K McEvoy","year":"2020","unstructured":"McEvoy K, Normile TG, Del Poeta M. Antifungal drug development: targeting the f Ungal sphingolipid pathway. J Fungi (Basel). 2020;6:142.","journal-title":"J Fungi (Basel)"},{"key":"4230_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/mmi.14586","volume":"114","author":"J Song","year":"2020","unstructured":"Song J, Liu X, Li R. Sphingolipids: regulators of Azole drug resistance and fungal pathogenicity. Mol Microbiol. 2020;114:891\u2013905.","journal-title":"Mol Microbiol"},{"key":"4230_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00294-013-0402-1","volume":"59","author":"R Prasad","year":"2013","unstructured":"Prasad R, Singh A. Lipids of Candida albicans and their role in multidrug resistance. Curr Genet. 2013;59:243\u201350.","journal-title":"Curr Genet"},{"key":"4230_CR41","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.celrep.2019.12.022","volume":"30","author":"SD Moreno-Vel\u00e1squez","year":"2020","unstructured":"Moreno-Vel\u00e1squez SD, Tint SH, Del Olmo Toledo V, Torsin S, De S, P\u00e9rez JC. The regulatory proteins Rtg1\/3 govern sphingolipid homeostasis in the human-associated yeast Candida albicans. Cell Rep. 2020;30:620-29.e6.","journal-title":"Cell Rep."}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04230-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:55:49Z","timestamp":1757350549000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4230"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04230-x","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols related to animals have obtained approval from the Animal Ethics Committee of Shanghai Skin Disease Hospital, Tongji University School of Medicine, and were accomplished under the international rules for animal research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"477"}}